Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study - Deterding, K; Spinner, C D; Schott, E (Lancet Infect Dis, 2017)
. doi:10.1016/S1473-3099(16)30408-X